Targeting estrogen-related receptors to mitigate tumor resistance: A comprehensive approach to bridging cellular energy metabolism
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-02 · 1880 (1) · 189256
DOI: 10.1016/j.bbcan.2024.189256 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-02. Verfasst von Yuan Ren und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Clinical Research Center for Gynecological Oncology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics &…. Hauptthemen laut MEDLINE: Energy Metabolism, Drug Resistance, Neoplasm, Receptors, Estrogen, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 126 Literaturangaben.
Abstract (Originalsprache)
The war between humanity and malignant tumors has been ongoing, with continuous advancements in classic chemotherapy and radiotherapy regimens, targeted drugs, endocrine therapy, and immunotherapy. However, tumor cells can develop primary or secondary resistance to these treatment options, making the issue of tumor resistance a major factor affecting patient prognosis and leading to recurrence. Estrogen-related receptors (ERRs) are members of the nuclear receptor superfamily, primarily involved in regulating glucose, lipid, and amino acid metabolism, serving as a central hub for intracellular energy metabolism. ERRs not only mediate insulin resistance but also participate in the mechanisms of drug resistance in various tumors, including breast cancer, osteosarcoma, endometrial cancer, lung cancer, and liver cancer, and even mediate resistance to radiation and immunotherapy. They mainly resist tumor treatment methods through metabolic reprogramming within cells, affecting mitochondrial energy metabolism, regulating metabolites such as cholesterol, glutamine, and lactate, or other signaling pathways, or by influencing the immune microenvironment. ERRs are promising targets for addressing the dilemma of tumor resistance. Currently, electrochemical luminescence biosensors for detecting ERRα in bodily fluids have been developed, making large-scale, low-cost detection of ERRα possible. Additionally, targeted inhibitors of ERRs have shown significant effects in suppressing cancer cell proliferation and reversing tumor resistance. This article reviews the research progress of ERRs in tumor resistance, providing important references for developing more effective anti-tumor treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Clinical Research Center for Gynecological Oncology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350001,…
- Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China.
- National Center for Occupational Safety and Health, Beijing, 102308, China; NHC Key Laboratory for Engineering Control of Dust Hazard, Beijing 102308, China.
Zitieren
APA
Ren, Y., Mao, X., Lin, W., Chen, Y., Chen, R., & Sun, P. (2025). Targeting estrogen-related receptors to mitigate tumor resistance: A comprehensive approach to bridging cellular energy metabolism. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(1), 189256. https://doi.org/10.1016/j.bbcan.2024.189256
Vancouver
Ren Y, Mao X, Lin W, Chen Y, Chen R, Sun P. Targeting estrogen-related receptors to mitigate tumor resistance: A comprehensive approach to bridging cellular energy metabolism. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(1):189256. doi:10.1016/j.bbcan.2024.189256
BibTeX
@article{Ren2025,
author = {Ren, Yuan and Mao, Xiaodan and Lin, Wenyu and Chen, Yi and Chen, Rongfeng and Sun, Pengming},
title = {Targeting estrogen-related receptors to mitigate tumor resistance: A comprehensive approach to bridging cellular energy metabolism},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
volume = {1880},
number = {1},
pages = {189256},
doi = {10.1016/j.bbcan.2024.189256}
}
EUVIMED